Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q3 2023 Earnings

14NovConfirmed

Nov 22

Q4 2022

Q2 2023

Q3 2023

-1.19

-0.79

-0.4

0

Details

Expected EPS

-1.19

Actual EPS

-0.86

Surprise EPS

0.33

Surprise Percent

+27.73%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.86 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.